GlucoTrack, Inc.
NASDAQ: GCTK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Paul V. Goode
- Employees
- 11
- Headquarters
- Or Yehuda, Israel
- IPO year
- 2013
- Market cap
- $198.6K
- Website
- https://www.glucotrack.com
Loading GCTK…
Loading profile data…Frequently asked questions about GCTK
What does GlucoTrack, Inc. (GCTK) do?
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is availab...
Where does GCTK trade?
GlucoTrack, Inc. (GCTK) trades on the NASDAQ Capital Market.
What sector is GCTK in?
GlucoTrack, Inc. (GCTK) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of GlucoTrack, Inc.?
Paul V. Goode is the chief executive officer of GlucoTrack, Inc. (GCTK).
Where is GlucoTrack, Inc. headquartered?
GlucoTrack, Inc. is headquartered in Israel.
Does GCTK pay a dividend?
GlucoTrack, Inc. (GCTK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GCTK go public?
GlucoTrack, Inc. (GCTK) completed its initial public offering in 2013.